Mode
Text Size
Log in / Sign up
N/A N=50 Randomized Single-blind Treatment

Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating

Binge Eating · Eating Disorders in Adolescence · Overweight and Obesity

Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Oct 2024
Primary outcome: Primary: Binge (Loss-of-control) Eating Episode Frequency — 1.52; 6.05 episodes of behavior — p=.01

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cognitive-Behavioral Therapy for Adolescent Binge/Loss-of-Control Eating (Behavioral); Control Condition (Other)
Age
Pediatric · 12+ yrs
Sex
All
Sponsor
Yale University
Primary completion
Oct 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Binge (Loss-of-control) Eating Episode Frequency
2.04; 5.94 .03 sig
PRIMARY
Weight (e.g., Percent Loss)
.02; .01
SECONDARY
Binge (Loss-of-control) Eating Episode Frequency
2.04; 5.94 .03 sig
SECONDARY
Weight (e.g., Percent Loss)
.02; .01

Summary

This study will develop and test a cognitive-behavioral intervention for adolescents with binge/loss-of-control eating.

Eligibility Criteria

Inclusion Criteria: To be included, adolescents must:

  • Be in the age range ≥12 years old and ≤17 years old;
  • Have a BMI that places them above the 85th percentile based on their age and sex;
  • Report 2 episodes of binge/LOC eating (feeling a loss of control while eating) per month for the past 3 months;
  • Be otherwise-healthy youth (i.e., no uncontrolled or serious medical conditions);
  • Read, comprehend, and write English at a sufficient level to complete study-related materials;
  • Be available for participation in the study for 7 months.

Exclusion Criteria: Prospective participants will be excluded if the adolescent:

  • Has a medical or psychiatric condition that would require hospitalization or intensive care (e.g., neurological disorder, psychotic disorders, suicidality);
  • Has a medical or psychiatric condition that would prohibit them from engaging in behavioral treatment or moderate physical activity (e.g., cardiovascular problems);
  • Has uncontrolled medical condition(s) (e.g., uncontrolled diabetes or hypertension);
  • Is pregnant or breastfeeding;
  • Is taking medication(s) or participating in treatment(s) that could influence weight or appetite;
  • Began taking hormonal contraceptives less than 3 months prior;
  • Has a developmental or cognitive disorder (e.g., autism spectrum disorder);
  • Has a concurrent feeding/eating disorder (e.g., bulimia nervosa); or
  • Is participating in another clinical research study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04088097). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search